AstraZeneca starts coronavirus vaccine trials in Japan

Drugmaker says it will deliver 30m doses to the country by next March

20200904N shot

AstraZeneca has signed an agreement with the Japanese government to supply the country with 120 million doses of a COVID-19 vaccine. © Reuters

RINA MITSUTAKE, Nikkei staff writer

September 4, 2020 23:52 JST

TOKYO -- AstraZeneca has begun clinical trials for a coronavirus vaccine candidate in Japan, its local unit announced Friday.

Read Next

Japan considers offering free COVID-19 vaccines to all residents

Japan considers offering free COVID-19 vaccines to all residents

Coronavirus: Free to read

Coronavirus: Week of Aug. 30 to Sept. 5, WHO warns against 'vaccine nationalism'

Coronavirus: Week of Aug. 30 to Sept. 5, WHO warns against 'vaccine nationalism'

Tokyo 2020 Olympics

Tokyo 2020 CEO says Olympics can proceed without COVID vaccine

Tokyo 2020 CEO says Olympics can proceed without COVID vaccine

Pharmaceuticals

AstraZeneca to supply Japan with 120m COVID-19 vaccine doses

AstraZeneca to supply Japan with 120m COVID-19 vaccine doses

China's Sinovac starts production of COVID-19 vaccine candidate

China's Sinovac starts production of COVID-19 vaccine candidate

Pharmaceuticals

Japan to shoulder COVID vaccine liability risks

Japan to shoulder COVID vaccine liability risks

Latest on Coronavirus

COVID-19 flares up in India; 44 dead, active cases top 4,300

COVID-19 flares up in India; 44 dead, active cases top 4,300

Thailand, Singapore and China mask up as COVID-19 reemerges

Thailand, Singapore and China mask up as COVID-19 reemerges

Japanese researchers eye COVID treatment derived from stem cells

Japanese researchers eye COVID treatment derived from stem cells

Sponsored Content